Wednesday, August 19, 2015
Ryan White HIV/AIDS Program anniversary
Thursday, June 27, 2013
National HIV Testing Day
- Have had unprotected sex (vaginal, anal, or oral) with multiple or anonymous partners;
- Have had unprotected sex with a partner who did not know their own HIV status;
- Have a history of sexually transmitted diseases (STDs); or
- Share needles/syringes or other equipment (“works”) for injecting drugs.
Wednesday, July 25, 2012
HIV updates
Home Testing
The US Food and Drug Administration (FDA) approved the first over-the-counter home-use rapid HIV test on July 3. The OraQuick In-Home HIV Test is designed to allow individuals to collect an oral fluid sample and obtain test results within 20 to 40 minutes.
A positive result with this test does not mean that an individual is definitely infected with HIV, but rather that additional testing should be done in a medical setting to confirm the test result. Similarly, a negative test result does not mean that an individual is definitely not infected with HIV, particularly when exposure may have been within the previous three months. The test has the potential to identify large numbers of previously undiagnosed HIV infections especially if used by those unlikely to use standard screening methods.
Pre-Exposure Prophylaxis
On July 16, FDA approved Truvada (a fixed dose combination of two antiretrovirals used to treat HIV) to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truvada is to be used for pre-exposure prophylaxis (PrEP) in combination with safer sex practices to prevent sexually-acquired HIV infection in adults at high risk. Truvada is the first drug approved for this indication.
Truvada for PrEP is meant to be used as part of a comprehensive HIV prevention plan that includes risk reduction counseling consistent and correct condom use, regular HIV testing, and screening for and treatment of other sexually-transmitted infections. Truvada is not a substitute for safer sex practices. As part of PrEP, HIV-uninfected individuals who are at high risk will need to take Truvada daily to lower their chances of becoming infected with HIV should they be exposed to the virus.
For more information about PrEP, visit http://www.cdc.gov/hiv/prep/
Prevention with Positives
Earlier this week, US CDC launched the first ever Prevention with Positives website to help address the prevention needs of people living with HIV/AIDS.
Trends in HIV-related Risk Behaviors Among High School Students
An early release MMWR article “Trends in HIV-Related Risk Behaviors Among High School Students — United States, 1991–2011” describes the analysis of data from the biennial national Youth Risk Behavior Survey (YRBS) with results that suggest that progress in reducing some HIV-related risk behaviors among high school students overall and in certain populations stalled in the past decade. The article suggests that renewed educational efforts and other risk reduction interventions are warranted to reduce the number of young persons who become infected with HIV.
Maine Reports
Maine's May 2012 HIV/STD update and 2011 HIV/STD Surveillance Report are now both posted on the Maine CDC website.
Wednesday, April 18, 2012
HIV/STD Updates
- March Monthly Update for HIV and STDs: http://go.usa.gov/yTR
- 2010 Annual HIV/STD Surveillance Report: http://go.usa.gov/yTQ
- A detailed report on HIV for 2011: http://go.usa.gov/yTE
- A detailed report on chlamydia and gonorrhea for 2011: http://go.usa.gov/yTV
Saturday, March 10, 2012
Women and Girls HIV/AIDS Awareness Day
- Women's bodies are different. A woman is twice as likely as a man to get HIV infection during vaginal sex (because the lining of the vagina provides a large area of potential exposure to HIV-infected semen). Some diseases or disorders unique to women make HIV more serious.
- Women can give HIV to their babies. Women who have HIV can give it to their babies during pregnancy, delivery, or breast-feeding.
- Women may lack control in relationships: they may be scared to refuse sex or insist that their partner use a condom, or can’t talk to their partner about abstinence, faithfulness, or using condoms.
- Women may not know if their partner is doing things that put him (and therefore her) at risk for HIV.
- Women may not earn much money, which makes it hard for them to pay doctors or even get a ride to their doctor appointments. In extreme instances, some women even end up trading sex for money or drugs.
- Women may be caregivers for others and not feel they have the time to take care of themselves or are unable to find someone to take care of their loved ones when they want to access services.
Tuesday, November 29, 2011
World AIDS Day
Wednesday, March 9, 2011
National Women and Girls HIV/AIDS Awareness Day
Women have unique issues and special challenges that make it harder for them to prevent HIV or take care of themselves if they have HIV:
- Women's bodies are different. A woman is twice as likely as a man to get HIV infection during vaginal sex (because the lining of the vagina provides a large area of potential exposure to HIV-infected semen). Some diseases or disorders unique to women make HIV more serious.
- Women can give HIV to their babies. Women who have HIV can give it to their babies during pregnancy, delivery, or breast-feeding.
- Women may lack control in relationships: they may be scared to refuse sex or insist that their partner use a condom, or can’t talk to their partner about abstinence, faithfulness, or using condoms.
- Women may not know if their partner is doing things that put him (and therefore her) at risk for HIV.
- Women may not earn much money, which makes it hard for them to pay doctors or even get a ride to their doctor appointments. In extreme instances, some women even end up trading sex for money or drugs.
- Women may be caregivers for others and not feel they have the time to take care of themselves or are unable to find someone to take care of their loved ones when they want to access services. Women may not earn much money, which makes it hard for them to pay doctors or even get a ride to their doctor appointments. In extreme instances, some women even end up trading sex for money or drugs.
What can providers do?
- Emphasize and make HIV testing a routine part of health care. Integrate HIV testing into reproductive health care and other key services.
- Reach out and educate, especially among young women and women of color. Many women want more information and are most likely to get it from doctors, other women with HIV/AIDS, the Internet, television, and radio.
- Decrease mother-to-child transmission by testing, educating, and treating.
- Prevent new infections by working with HIV-infected partners.
- Improve access to care and support services for women, as well as support women’s roles as caregivers and mothers.
Friday, February 18, 2011
Update on HIV, STDs, and Viral Hepatitis
The Maine HIV, STD, and Viral Hepatitis program has updated its web site. For easy access to information and resources, check out www.mainepublichealth.gov/hivstdhep
The Sixth Annual Comprehensive Sexuality Education Conference will be held from 8:30 a.m. to 3:30 p.m. April 7 at the Augusta Civic Center.
Keynote speaker is Pamela Wilson, M.S.W., author of Our Whole lives: Sexuality Education for Grades 7-9. Workshops focus on foundational knowledge and skills, networking opportunities, and innovative ideas to put into practice.
The cost is $40 before March 18 and $50 after March 18.
The conference is co-sponsored by: Family Planning Association of Maine; Maine Department of Education; Maine Center for Disease Control & Prevention, an Office of the Department of Health & Human Services; New Beginnings; University of Maine Farmington; and the Maine Association for Health, Physical Education, Recreation, and Dance.
For more information and to register: https://www.mainefamilyplanning.org/forms/conference_form.php
HIV
The Institute of Medicine (IOM) has released the report HIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision of HIV Care. The report examines how Federal and State laws and policies and private health insurance policies affect entry into clinical care and the provision of continuous and sustained care for people with HIV.
US CDC has published an article on disparities in HIV diagnoses among African Americans and other racial and ethnic minorities.
STDs
US CDC published the article “Discordant Results from Reverse Sequence Syphilis Screening” in the MMWR.
Viral Hepatitis
US CDC has made new patient education materials related to hepatitis available on its website.
The following articles have been published in the MMWR:
Tuesday, November 30, 2010
HIV/STD Update
World AIDS Day
December 1 is World AIDS Day. There are approximately 1,462 people estimated to be living in Maine with diagnosed HIV infection. In addition, Maine CDC estimates that about 388 people in Maine may be infected but unaware of their HIV status. Worldwide, more than 33 million people are estimated to be living with HIV. For more information on World AIDS Day: http://www.aids.gov/world-aids-day/ For more information on HIV/AIDS in Maine: www.mainepublichealth.gov/hivstdhep
Syphilis
Since mid-July, health care providers in Maine have diagnosed 19 cases of early syphilis, ages 19-56, in Cumberland, Penobscot, Waldo and York Counties. Eleven cases were primary syphilis, 5 cases were secondary syphilis, and 3 cases were early latent syphilis. All 19 cases were among men who have sex with men (MSM). Eight of the 19 individuals (42%) are known to be HIV positive. A total of 33 cases of early syphilis have been reported since the beginning of the calendar year. For more information, see this Health Alert: http://www.maine.gov/tools/whatsnew/index.php?topic=DHHS-HAN&id=152027&v=alert
PrEP
The National Institutes of Health (NIH) has announced the results of an international clinical trial, co-sponsored by the Bill and Melinda Gates Foundation, that examined whether a pill containing two drugs used to treat HIV can also help prevent HIV infection – an approach called pre-exposure prophylaxis, or PrEP. The trial found that daily oral use of Truvada ® provided an average of 44 percent additional protection to trial participants that included gay, bisexual, and other men who have sex with men (MSM), as well as transgendered women who have sex with men. These participants also received a comprehensive package of prevention services that included monthly HIV testing, condom provision, counseling, and management of other sexually transmitted infections.
US CDC will fully review the trial data and publish interim guidance in the coming weeks in the Morbidity and Mortality Weekly Report, to be followed in several months by formal U.S. Public Health Service guidelines. The agency urges individuals and their doctors to await those guidelines before use. For more information, please refer to the PrEP fact sheet: http://www.cdc.gov/nchhstp/newsroom/PrEPforHIVFactSheet.html
This blog has additional information from the White House.
Sixth Annual Comprehensive Sexuality Education Conference
Save the date for the sixth annual Comprehensive Sexuality Education Conference, which will be held April 7 at the Augusta Civic Center. It is sponsored by: Family Planning Association of Maine; Maine Department of Education, Maine CDC; New Beginnings; University of Maine at Farmington; and the Maine Association for Health, Physical Education, Recreation, and Dance.